Pluronic F-127/Silk Fibroin for Enhanced Mechanical Property and Sustained Release Drug for Tissue Engineering Biomaterial
Open Access
- 8 March 2021
- Vol. 14 (5), 1287
- https://doi.org/10.3390/ma14051287
Abstract
Herein, an injectable thermosensitive hydrogel was developed for a drug and cellular delivery system. The composite was prepared by facile physical mixing of pluronic F-127 (PF) and silk fibroin (SF) in an aqueous solution. The chemical structure, transparency, viscosity, injectability, degradation kinetic, cumulative release of dexamethasone (Dex), a type of corticosteroid drug, and size distribution of the fabricated hydrogels were characterized. Cytotoxicity of the hydrogels was also studied to verify the biocompatibility of the hydrogels. The addition of a proper amount of SF to PF not only improved the mechanical strength but also decreased the degradation rate which improved the fast rate release of hydrophobic drugs. The cytotoxicity of the hydrogel decreased when SF was added to PF in a proper amount. Overall, the results confirm that the composite of PF and SF can be a promising cell and drug delivery system for future application in tissue engineering and regenerative medicine.Keywords
Funding Information
- National Research Foundation of Korea (NRF-2020R1A2C2103089)
This publication has 56 references indexed in Scilit:
- Calcium phosphate ceramic systems in growth factor and drug delivery for bone tissue engineering: A reviewActa Biomaterialia, 2012
- Thermoreversible Pluronic® F127-based hydrogel containing liposomes for the controlled delivery of paclitaxel: in vitro drug release, cell cytotoxicity, and uptake studiesInternational Journal of Nanomedicine, 2011
- An anisotropic nanofiber/microsphere composite with controlled release of biomolecules for fibrous tissue engineeringBiomaterials, 2010
- Thermosensitive injectable hyaluronic acid hydrogel for adipose tissue engineeringBiomaterials, 2009
- Self-assembled silk sericin/poloxamer nanoparticles as nanocarriers of hydrophobic and hydrophilic drugs for targeted deliveryNanotechnology, 2009
- Dual-drug delivery system based on hydrogel/micelle compositesBiomaterials, 2009
- Safety Assessment of Poloxamers 101, 105, 108, 122, 123, 124, 181, 182, 183, 184, 185, 188, 212, 215, 217, 231, 234, 235, 237, 238, 282, 284, 288, 331, 333, 334, 335, 338, 401, 402, 403, and 407, Poloxamer 105 Benzoate, and Poloxamer 182 Dibenzoate as Used in CosmeticsInternational Journal of Toxicology, 2008
- Engineering adipose-like tissue in vitro and in vivo utilizing human bone marrow and adipose-derived mesenchymal stem cells with silk fibroin 3D scaffoldsBiomaterials, 2007
- Synthesis and characterization of a fluvastatin-releasing hydrogel delivery system to modulate hMSC differentiation and function for bone regenerationBiomaterials, 2006
- Pluronic F127 as a Cell Encapsulation Material: Utilization of Membrane-Stabilizing AgentsTissue Engineering, 2005